A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial tumor suppressor protein is frequently disabled in various forms of cancer, leading https://bookmarkshut.com/story23598282/mini-antibodies-reactivate-the-p53-protein-new-potential-pathway-for-tumor-therapy